Combination of Navepegritide and Lonapegsomatropin administered as two separate s.c. injections clinical trials

A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia

This study is looking at a new way to treat achondroplasia in children aged 2-11. It combines two existing medicines, navepegritide and lonapegsomatropin, given as weekly injections, to see if they can work better together.